Cellebrite Di Ltd (CLBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 89,181 | 125,719 | 145,973 | 109,886 | 866 |
| Marketable Securities | 50,829 | 40,208 | 35,592 | 61,801 | N/A |
| Receivables | 66,746 | 60,297 | 67,505 | 76,215 | N/A |
| Inventories | 8,116 | 7,858 | 6,511 | 4,808 | N/A |
| Other current assets | 4,601 | 4,456 | 4,813 | 4,563 | 0 |
| TOTAL | $231,138 | $250,134 | $273,212 | $271,328 | $1,236 |
| Non-Current Assets | |||||
| PPE Net | 17,775 | 17,752 | 16,756 | 16,392 | N/A |
| Investments And Advances | 25,335 | 6,475 | 0 | 0 | 600,132 |
| Intangibles | 36,730 | 37,393 | 38,057 | 17,775 | 0 |
| Other Non-Current Assets | 13,864 | 12,871 | 11,758 | 9,654 | 0 |
| TOTAL | $93,704 | $74,491 | $66,571 | $43,821 | $600,132 |
| Total Assets | $324,842 | $324,625 | $339,783 | $315,149 | $601,368 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 51,228 | 52,771 | 63,590 | 57,488 | 74 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 2,070 |
| Other current liabilities | N/A | N/A | N/A | 231,215 | N/A |
| TOTAL | $172,873 | $170,556 | $186,573 | $403,720 | $2,189 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 121,645 | 117,785 | 122,983 | 115,017 | N/A |
| Other Non-Current Liabilities | 92,435 | 131,123 | 190,131 | 7,015 | 573,179 |
| TOTAL | $127,911 | $166,290 | $226,557 | $41,413 | $594,179 |
| Total Liabilities | $300,784 | $336,846 | $413,130 | $445,133 | $596,368 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | 188,541 | N/A | 75,000 |
| Common Shares | N/A | N/A | N/A | N/A | 2 |
| Retained earnings | 167,073 | 133,876 | 78,438 | 26,518 | -21,576 |
| Other shareholders' equity | -1,094 | 490 | 1,287 | -163 | 0 |
| TOTAL | $24,058 | $-12,221 | $-73,347 | $-129,984 | $5,000 |
| Total Liabilities And Equity | $324,842 | $324,625 | $339,783 | $315,149 | $601,368 |